1. Today the Federal Circuit rejected Teva’s bid to list device patents for inhalers in the Orange Book.
Practically this means that drug makers can’t list patents for things like inhaler caps to block generic rivals from the market & keep prices high.
A big win for Americans. https://t.co/sEYPwmVrfs
— Lina Khan (@linamkhan)
Dec 20, 2024
from http://twitter.com/linamkhan
via IFTTT